A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called
Masked T‑cell engagers: cancer immunotherapies for the future?
- Advertisement -
Previous article![]( "Myanmar: WFP reports fragile recovery, one year after deadly earthquake")
Next article![]( "World news in brief: Cuba’s blockade hits health care, Haiti’s ‘vortex of violence’ and Djibouti’s deadly shipwreck")
A new immunotherapy drug has demonstrated early promise in a recent prostate cancer clinical trial. The drug, called
